A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|67|2|467-469

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.67, Iss.2, 2018-02, pp. : 467-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Post‐embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma

By  

HPB, Vol. 17, Iss. 12, 2015-12 ,pp. : 1137-1144

John Wiley & Sons Inc

Access to resources Recommend Favorite

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma

By Kim J. S.   Kwak B. K.   Shim H. J.   Lee Y. C.   Baik H. W.   Lee M. J.   Han S-M.   Son S. H.   Kim Y. B.   Tokura S.   Lee B. M.  

Journal of Microencapsulation, Vol. 24, Iss. 5, 2007-01 ,pp. : 408-419

Informa Healthcare

Access to resources Recommend Favorite

Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Recent Progression and Perspective

By  

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 28-33

Karger

Access to resources Recommend Favorite

Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma

By  

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 40-43

Karger

Access to resources Recommend Favorite